Sharon Ansboro

608 total citations
9 papers, 461 citations indexed

About

Sharon Ansboro is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, Sharon Ansboro has authored 9 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Rheumatology. Recurrent topics in Sharon Ansboro's work include Osteoarthritis Treatment and Mechanisms (4 papers), Mesenchymal stem cell research (3 papers) and CAR-T cell therapy research (2 papers). Sharon Ansboro is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (4 papers), Mesenchymal stem cell research (3 papers) and CAR-T cell therapy research (2 papers). Sharon Ansboro collaborates with scholars based in Ireland, United Kingdom and Netherlands. Sharon Ansboro's co-authors include Anke J. Roelofs, Cosimo De Bari, Ursula Fearon, Douglas J. Veale, Janja Zupan, Nathan White, Anna H.K. Riemen, Karolina Kania, Mary Murphy and Frank Barry and has published in prestigious journals such as Nature Communications, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Sharon Ansboro

9 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Ansboro Ireland 8 195 149 140 75 63 9 461
Karolina Kania United Kingdom 6 209 1.1× 163 1.1× 109 0.8× 94 1.3× 40 0.6× 8 412
A. De la Fuente Spain 11 152 0.8× 241 1.6× 221 1.6× 124 1.7× 58 0.9× 17 527
Hiraku Motomura Japan 10 144 0.7× 129 0.9× 76 0.5× 114 1.5× 44 0.7× 14 410
Verena Dexheimer Germany 8 185 0.9× 145 1.0× 179 1.3× 117 1.6× 49 0.8× 8 426
Nakia D. Spencer United States 10 76 0.4× 116 0.8× 166 1.2× 136 1.8× 75 1.2× 14 439
David Guérit France 10 221 1.1× 333 2.2× 150 1.1× 81 1.1× 65 1.0× 16 667
Thomas E. Uveges United States 9 199 1.0× 190 1.3× 69 0.5× 96 1.3× 106 1.7× 9 670
Helen S. McCarthy United Kingdom 14 315 1.6× 200 1.3× 108 0.8× 229 3.1× 115 1.8× 30 661
Masami Kanawa Japan 10 65 0.3× 120 0.8× 202 1.4× 113 1.5× 41 0.7× 20 389
Mathew G. Angelos United States 9 96 0.5× 184 1.2× 42 0.3× 106 1.4× 94 1.5× 20 436

Countries citing papers authored by Sharon Ansboro

Since Specialization
Citations

This map shows the geographic impact of Sharon Ansboro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Ansboro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Ansboro more than expected).

Fields of papers citing papers by Sharon Ansboro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Ansboro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Ansboro. The network helps show where Sharon Ansboro may publish in the future.

Co-authorship network of co-authors of Sharon Ansboro

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Ansboro. A scholar is included among the top collaborators of Sharon Ansboro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Ansboro. Sharon Ansboro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Petrasca, Andreea, J.J. Phelan, Sharon Ansboro, et al.. (2020). Targeting bioenergetics prevents CD4 T cell–mediated activation of synovial fibroblasts in rheumatoid arthritis. Lara D. Veeken. 59(10). 2816–2828. 55 indexed citations
3.
Hanlon, Megan M., Tatsiana Rakovich, Clare C. Cunningham, et al.. (2019). STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function. Frontiers in Immunology. 10. 2056–2056. 69 indexed citations
4.
Roelofs, Anke J., Janja Zupan, Anna H.K. Riemen, et al.. (2017). Joint morphogenetic cells in the adult mammalian synovium. Nature Communications. 8(1). 15040–15040. 139 indexed citations
5.
Ansboro, Sharon, Anke J. Roelofs, & Cosimo De Bari. (2016). Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?. Current Opinion in Rheumatology. 29(2). 201–207. 85 indexed citations
6.
Barron, Valerie, Georgina Shaw, Cynthia M. Coleman, et al.. (2015). Evaluation of Cartilage Repair by Mesenchymal Stem Cells Seeded on a PEOT/PBT Scaffold in an Osteochondral Defect. Annals of Biomedical Engineering. 43(9). 2069–2082. 23 indexed citations
7.
Barron, Valerie, Sharon Ansboro, Georgina Shaw, et al.. (2015). Evaluation of the Early In Vivo Response of a Functionally Graded Macroporous Scaffold in an Osteochondral Defect in a Rabbit Model. Annals of Biomedical Engineering. 44(5). 1832–1844. 15 indexed citations
8.
Ansboro, Sharon, Jessica S Hayes, Valerie Barron, et al.. (2014). A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells. Journal of Controlled Release. 179. 42–51. 30 indexed citations
9.
Ansboro, Sharon, Udo Greiser, Frank Barry, & Mary Murphy. (2012). Strategies for improved targeting of therapeutic cells: Implications for tissue repair. European Cells and Materials. 23. 310–319. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026